BeOne culls five cancer programs and an autoimmune Phase 2news2026-05-06T18:22:20+00:00May 6th, 2026|Endpoints News|
Lonza looks to ride ADC wave with upcoming factory, workforce expansionnews2026-05-06T18:06:38+00:00May 6th, 2026|Endpoints News|
GSK goes to China for $1B siRNA deal in Arrowhead’s obesity lanenews2026-05-06T13:39:55+00:00May 6th, 2026|Endpoints News|
Novo Nordisk’s Q1 in four words: Pills, pricing, payments and pressurenews2026-05-06T10:27:04+00:00May 6th, 2026|Endpoints News|
Pfizer’s Albert Bourla says he has no mega-merger plansnews2026-05-05T18:16:42+00:00May 5th, 2026|Endpoints News|
BioNTech to scale down manufacturing, over 1,800 jobs on the linenews2026-05-05T16:53:50+00:00May 5th, 2026|Endpoints News|
Swiss manufacturing, biotech industry so far unfazed by geopoliticsnews2026-05-05T14:55:55+00:00May 5th, 2026|Endpoints News|
Pfizer ends Trillium-related development as R&D spend jumpsnews2026-05-05T14:41:28+00:00May 5th, 2026|Endpoints News|
Madrigal extends MASH deal streak with Arrowhead drug that J&J didn’t wantnews2026-05-05T13:25:50+00:00May 5th, 2026|Endpoints News|
Cytokinetics succeeds where Bristol Myers failed in heart muscle diseasenews2026-05-05T11:30:51+00:00May 5th, 2026|Endpoints News|
